{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T12:49:18Z","timestamp":1770554958099,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T00:00:00Z","timestamp":1657411200000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"NRF","doi-asserted-by":"publisher","award":["2020R1A2C1101104"],"award-info":[{"award-number":["2020R1A2C1101104"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"NRF","doi-asserted-by":"publisher","award":["NRF-2017M3A9G6068246"],"award-info":[{"award-number":["NRF-2017M3A9G6068246"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bbrc.2021.07.019","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T11:22:17Z","timestamp":1625916137000},"page":"193-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits"],"prefix":"10.1016","volume":"569","author":[{"given":"Hyeryon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Hwa","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-7490","authenticated-orcid":false,"given":"Trong-Nhat","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I Seul","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangchul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Hwan","family":"No","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.07.019_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"Ready","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.bbrc.2021.07.019_bib2","first-page":"557","article-title":"Global leishmaniasis update, 2006-2015: a turning point in leishmaniasis surveillance","volume":"92","year":"2017","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.bbrc.2021.07.019_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbrc.2021.07.019_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00048-18","article-title":"Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives","volume":"31","author":"Alves","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2021.07.019_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/AAC.01788-12","article-title":"Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation","volume":"57","author":"Wyllie","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2021.07.019_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpddr.2018.01.006","article-title":"In\u00a0vitro and in\u00a0vivo pharmacodynamics of three novel antileishmanial lead series","volume":"8","author":"Van den Kerkhof","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bbrc.2021.07.019_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acs.jmedchem.8b01218","article-title":"Identification of gsk3186899\/DDD853651 as a preclinical development candidate for the treatment of visceral leishmaniasis","volume":"62","author":"Thomas","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2021.07.019_bib8","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selective proteasome inhibitor for the treatment of leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2021.07.019_bib9","series-title":"DNDi","year":"2020"},{"key":"10.1016\/j.bbrc.2021.07.019_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-0-387-77570-8_9","article-title":"DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy","volume":"625","author":"Das","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2021.07.019_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2021.07.019_bib12","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A\u00a0novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.07.019_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073565","article-title":"Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB","volume":"8","author":"Prada","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.07.019_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jmb.2006.01.022","article-title":"The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA","volume":"357","author":"Davies","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2021.07.019_bib15","doi-asserted-by":"crossref","first-page":"e1177","DOI":"10.1371\/journal.pone.0001177","article-title":"Deletion study of DNA topoisomerase IB from Leishmania donovani: searching for a minimal functional heterodimer","volume":"2","author":"Diaz Gonzalez","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.07.019_bib16","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbrc.2021.07.019_bib17","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1128\/AAC.00352-16","article-title":"A\u00a0novel spirooxindole derivative inhibits the growth of Leishmania donovani parasites both in\u00a0vitro and in\u00a0vivo by targeting type IB topoisomerase","volume":"60","author":"Saha","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2021.07.019_bib18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/emmm.201201316","article-title":"The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice","volume":"4","author":"Chowdhury","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2021.07.019_bib19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1128\/AAC.45.5.1349-1354.2001","article-title":"Antileishmanial activity of an indole alkaloid from Peschiera australis","volume":"45","author":"Delorenzi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2021.07.019_bib20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12906-016-1401-9","article-title":"Essential oils: in\u00a0vitro activity against Leishmania amazonensis, cytotoxicity and chemical composition","volume":"16","author":"Andrade","year":"2016","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.bbrc.2021.07.019_bib21","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1128\/AAC.01129-16","article-title":"Antileishmanial mechanism of diamidines involves targeting kinetoplasts","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2021.07.019_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9050393","article-title":"Infectivity and drug susceptibility profiling of different leishmania-host cell combinations","volume":"9","author":"Baek","year":"2020","journal-title":"Pathogens"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21010512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21010512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:09:32Z","timestamp":1757765372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21010512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":22,"alternative-id":["S0006291X21010512"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.07.019","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}